<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000819'>Diabetes mellitus</z:hpo> is associated with <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e>, <z:e sem="disease" ids="C0020476" disease_type="Disease or Syndrome" abbrv="">hyperlipoproteinaemia</z:e>, increased <z:mp ids='MP_0003674'>oxidative stress</z:mp> and decreased nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> production from endothelial cells </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study the aim was to determine the relationships between serum <z:chebi fb="23" ids="18059">lipids</z:chebi>, <z:chebi fb="2" ids="6495">lipoproteins</z:chebi>, erythrocyte malondialdehyde (eMDA), as a marker for <z:mp ids='MP_0003674'>oxidative stress</z:mp>, and serum <z:chebi fb="95" ids="16301">nitrite</z:chebi> and nitrate levels, as degradation products of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> in type 2 diabetic patients without complications </plain></SENT>
<SENT sid="2" pm="."><plain>The study group included 30 patients and 30 sex- and age-matched healthy volunteers </plain></SENT>
<SENT sid="3" pm="."><plain>Total cholesterol, triacylglycerol, <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi>, apo B, HbA(1c) and <z:chebi fb="105" ids="17234">glucose</z:chebi> levels in patients were significantly higher than in controls, and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> levels lower </plain></SENT>
<SENT sid="4" pm="."><plain>Increased eMDA levels and decreased nitrate and <z:chebi fb="95" ids="16301">nitrite</z:chebi>+nitrate levels (+/-SD) were observed in patients compared to controls (87+/-22 vs 59+/-17 nmol/g-Hb (P&lt;0.01); 11.8+/-8.6 vs 22.8+/-10.8 micromol/l (P&lt;0.01); and 16.8+/-11.0 vs 28.8+/-11.3 micromol/l (P&lt;0.01), respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>When the patients were divided into two groups according to <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> levels (&lt; or =0.91 and &gt;0.91 mmol/l), total plasma nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> end-products were found to be decreased in patients with low <z:chebi fb="17" ids="39025">HDL</z:chebi> levels compared to those patients with high <z:chebi fb="17" ids="39025">HDL</z:chebi> levels [men, 11.7+/-6.4 vs 24.6+/-14.9 micromol/l (P&lt;0.01); women, 12.5+/-6.6 vs 21.4+/-6.6 micromol/l (P&lt;0.01] </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="95" ids="16301">Nitrite</z:chebi> and nitrate levels were correlated with <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (r=0.50, P&lt;0.05) and eMDA (r=-0.52, P&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>It was concluded that the patients with unregulated blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels have abnormal <z:chebi fb="23" ids="18059">lipid</z:chebi> and <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> metabolism and decreased nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> end-products, with relationships between nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> products and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e>, especially between <z:hpo ids='HP_0003233'>low HDL cholesterol</z:hpo> levels and increased <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
</text></document>